A randomized phase 2 study of etaracizumab, a monoclonal antibody against integrin alpha(v)beta(3), + or - dacarbazine in patients with stage IV metastatic melanoma.
Authors : Hersey Peter P; Sosman Jeffrey J; O'Day Steven S; Richards Jon J; Bedikian Agop A; Gonzalez Rene R; Sharfman William W; Weber Robert R; Logan Theodore T; Buzoianu Manuela M; Hammershaimb Luz L; Kirkwood John M JM; ;
Affiliations : Newcastle Melanoma Unit, Newcastle, Australia.
Journal : Cancer (2010)
Related Links: Pubmed | Publisher website
Display Ads on JAFIB to reach Users world wide...
Suggest an Event to get good mileage from Users World wide...